Clinical Trial

Effects of taVNS on Fibromyalgia Pain

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Transauricular vagus nerve stimulation (taVNS) is a newer delivery system, using a non-invasive stimulation device placed at the ear's concha. TaVNS is a portable, safe, and low-cost intervention, and according to some studies, taVNS may influence nociception and pain perception, which can lead to potential applications for various painful illnesses, including fibromyalgia (FM). This trial aims to investigate the clinical effects of taVNS on pain control in FM subjects.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-12-21; most recent amendment 2025-09-15.
Trial Details
NCT Number NCT06193317
Lead Sponsor Spaulding Rehabilitation Hospital
Conditions Fibromyalgia, Pain
Enrollment 152 participants
Start Date 2026-06-01
Primary Completion 2028-05-01 (estimated)
Study Completion 2029-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-19